Summary Slide.png (108.7 kB)
Real-world Comparative Effectiveness of Canagliflozin Versus Empagliflozin and Dapagliflozin in Patients with Type 2 Diabetes in the United States
figure
posted on 2020-11-02, 11:53 authored by Lawrence Blonde, Charmi Patel, Bingcao Wu, Yen-Wen Chen, Christopher D. Pericone, Brahim BookhartArticle full text
The above Summary Slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.
